Gelteq Short Interest Declines 28.2% in March

Biotechnology company sees reduced short selling activity in latest reporting period.

Apr. 16, 2026 at 1:18am

Got story updates? Submit your updates here. ›

An extreme close-up photograph of complex financial machinery and circuits in shades of steel grey, copper, and black, conceptually representing the complex infrastructure and mechanics of the banking and finance industry.The decline in short interest for Gelteq's stock may signal improving investor confidence in the biotechnology company's financial outlook.NYC Today

Gelteq Limited (NASDAQ:GELS), a biotechnology company focused on ingestible gel delivery solutions, saw a significant 28.2% decline in short interest during the month of March. As of March 31st, the total short interest in Gelteq shares was 72,024, down from 100,277 shares two weeks earlier.

Why it matters

Short interest can be an indicator of investor sentiment, with higher short interest suggesting more bearish views on a company's prospects. The decline in Gelteq's short interest may signal improving confidence in the stock among some investors, though the company still maintains a 'Sell' rating from one analyst.

The details

Gelteq's short interest ratio, which measures the number of shares sold short relative to the stock's average daily trading volume, currently stands at 7.7 days. This suggests the short positions could be covered relatively quickly. The company's stock price has traded in a range of $0.64 to $4.11 over the past 52 weeks, closing most recently at $0.70 per share.

  • As of March 31st, 2026, Gelteq had 72,024 shares sold short.
  • This represents a 28.2% decline from the 100,277 shares sold short as of March 15th, 2026.

The players

Gelteq Limited

A biotechnology company that specializes in the formulation, development and manufacturing of ingestible gel platforms designed for nutrient and drug delivery.

Weiss Ratings

An investment research firm that has maintained a 'sell (e+)' rating on Gelteq's shares.

Got photos? Submit your photos here. ›

The takeaway

The decline in short interest for Gelteq may suggest improving investor sentiment, though the company still faces a 'Sell' rating from one analyst. The stock's trading range and short interest ratio indicate it remains a volatile investment with potential risks.